James N. Ingle
Mayo Clinic
Rochester
MN 55905
USA
Name/email consistency: high
- Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. Ingle, J.N., Schaid, D.J., Goss, P.E., Liu, M., Mushiroda, T., Chapman, J.A., Kubo, M., Jenkins, G.D., Batzler, A., Shepherd, L., Pater, J., Wang, L., Ellis, M.J., Stearns, V., Rohrer, D.C., Goetz, M.P., Pritchard, K.I., Flockhart, D.A., Nakamura, Y., Weinshilboum, R.M. J. Clin. Oncol. (2010)
- Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. Ingle, J.N., Buzdar, A.U., Schaid, D.J., Goetz, M.P., Batzler, A., Robson, M.E., Northfelt, D.W., Olson, J.E., Perez, E.A., Desta, Z., Weintraub, R.A., Williard, C.V., Flockhart, D.A., Weinshilboum, R.M. Cancer Res. (2010)
- Pharmacogenomics of tamoxifen and aromatase inhibitors. Ingle, J.N. Cancer (2008)
- Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17. Ingle, J.N., Tu, D., Pater, J.L., Muss, H.B., Martino, S., Robert, N.J., Piccart, M.J., Castiglione, M., Shepherd, L.E., Pritchard, K.I., Livingston, R.B., Davidson, N.E., Norton, L., Perez, E.A., Abrams, J.S., Cameron, D.A., Palmer, M.J., Goss, P.E. Ann. Oncol. (2008)
- Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer. Ingle, J.N. Breast Cancer Res. (2008)
- Adjuvant endocrine therapy for postmenopausal women with early breast cancer. Ingle, J.N. Clin. Cancer Res. (2006)
- Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032. Ingle, J.N., Suman, V.J., Rowland, K.M., Mirchandani, D., Bernath, A.M., Camoriano, J.K., Fishkin, P.A., Nikcevich, D.A., Perez, E.A. J. Clin. Oncol. (2006)
- Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Ingle, J.N., Suman, V.J., Mailliard, J.A., Kugler, J.W., Krook, J.E., Michalak, J.C., Pisansky, T.M., Wold, L.E., Donohue, J.H., Goetz, M.P., Perez, E.A. Breast Cancer Res. Treat. (2006)
- Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings. Ingle, J.N. Clin. Cancer Res. (2005)
- Aromatase inhibitors for therapy of advanced breast cancer. Ingle, J.N., Suman, V.J. J. Steroid Biochem. Mol. Biol. (2005)
- Sequencing of endocrine therapy in postmenopausal women with advanced breast cancer. Ingle, J.N. Clin. Cancer Res. (2004)
- Adjuvant endocrine therapy in postmenopausal breast cancer. Ingle, J.N. Clin. Cancer Res. (2003)
- Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings. Ingle, J.N., Suman, V.J. J. Steroid Biochem. Mol. Biol. (2003)
- Estrogen as therapy for breast cancer. Ingle, J.N. Breast Cancer Res. (2002)
- Sequencing of hormonal therapy in breast cancer. Ingle, J.N. Breast. J (2002)
- Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. Ingle, J.N. Oncology (Williston Park, N.Y.) (2001)
- Current status of adjuvant endocrine therapy for breast cancer. Ingle, J.N. Clin. Cancer Res. (2001)
- Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Ingle, J.N., Suman, V.J., Johnson, P.A., Krook, J.E., Mailliard, J.A., Wheeler, R.H., Loprinzi, C.L., Perez, E.A., Jordan, V.C., Dowsett, M. Clin. Cancer Res. (1999)
